BeiGene Net Income from 2010 to 2026

ONC Stock   340.38  9.62  2.75%   
BeiGene's Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -609.3 M. During the period from 2010 to 2026 BeiGene Net Loss annual values regression line had coefficient of variation of (111.04) and r-squared of  0.41. View All Fundamentals
 
Net Loss  
First Reported
2014-03-31
Previous Quarter
94.3 M
Current Value
124.8 M
Quarterly Volatility
209.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 207.4 M, Interest Expense of 63.4 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 0.67, Dividend Yield of 0.0 or PTB Ratio of 0.61. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
  
Build AI portfolio with BeiGene Stock
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
Analyzing BeiGene's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing BeiGene's current valuation and future prospects.

Latest BeiGene's Net Income Growth Pattern

Below is the plot of the Net Income of BeiGene over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BeiGene financial statement analysis. It represents the amount of money remaining after all of BeiGene operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BeiGene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (644.79 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

BeiGene Net Income Regression Statistics

Arithmetic Mean(573,106,128)
Coefficient Of Variation(111.04)
Mean Deviation502,020,120
Median(580,307,400)
Standard Deviation636,353,431
Sample Variance404945.7T
Range2B
R-Value(0.64)
Mean Square Error253672.1T
R-Squared0.41
Significance0.01
Slope(80,957,042)
Total Sum of Squares6479131T

BeiGene Net Income History

2026-609.3 M
2025-580.3 M
2024-644.8 M
2023-881.7 M
2022-2 B
2021-1.5 B
2020-1.6 B

Other Fundumenentals of BeiGene

BeiGene Net Income component correlations

About BeiGene Financial Statements

BeiGene stakeholders use historical fundamental indicators, such as BeiGene's Net Income, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-580.3 M-609.3 M
Net Loss-741.5 M-778.6 M
Net Loss(7.04)(7.39)
Net Income Per E B T 1.09  0.82 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Biotechnology sector continue expanding? Could BeiGene diversify its offerings? Factors like these will boost the valuation of BeiGene. Anticipated expansion of BeiGene directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BeiGene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
0.51
Revenue Per Share
45.987
Quarterly Revenue Growth
0.41
Return On Assets
0.0169
Return On Equity
0.0181
Understanding BeiGene requires distinguishing between market price and book value, where the latter reflects BeiGene's accounting equity. The concept of intrinsic value—what BeiGene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push BeiGene's price substantially above or below its fundamental value.
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, BeiGene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.